Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | SLC5A2 | P31639 | 14/20 | 0.54 |
| ▸ | SLC5A1 | P13866 | 9/20 | 0.47 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9238330 | 0.87 | ATM (0.58) | ATMSLC5A2SLC5A1 | |
| SCHEMBL6037241 | 0.87 | ATM (0.43) | ATMSLC5A2SLC5A1 | |
| SCHEMBL3724838 | 0.85 | ATM (0.65) | ATMSLC5A2SLC5A1 | |
| SCHEMBL31741260 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL3406202 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL3719106 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL7191502 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL2191348 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL3805865 | 0.84 | ATM (0.67) | ATMSLC5A2SLC5A1 | |
| SCHEMBL6037248 | 0.81 | ATM (0.52) | ATMSLC5A2SLC5A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060094031-A1 | Alpha-L-arabinofuranosidase histochemical reporter gene assay | STOWERS INSTITUTE FOR MEDICAL RESEARCH | 2006-05-04 | — | — | US | claimed |
| US-20060094031-A1 | Alpha-L-arabinofuranosidase histochemical reporter gene assay | STOWERS INSTITUTE FOR MEDICAL RESEARCH | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094031-A1 | Alpha-L-arabinofuranosidase histochemical reporter gene assay | GUSB, FUCA1, ENGASE | ATM 4743/4885SLC5A2 780/4885SLC5A1 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.